Pfizer CEO Albert Bourla said Wednesday that people might need a fourth Covid-19 shot sooner than expected after preliminary research shows the new omicron variant can undermine protective antibodies generated by the vaccine the company developed with BioNTech.
Pfizer and BioNTech released results from an initial lab study Wednesday morning that showed a third shot is effective at fighting the omicron variant, while the initial two-dose vaccination series dropped significantly in its ability to protect against the new strain. However, the two-dose series likely still offers protection against getting severely sick from omicron, the companies said.

Bourla noted that a preliminary study by the company was based on a synthetic, lab-created copy of the variant and more data is needed from tests against the real virus. Those real-world results will be more accurate and are expected in the next two weeks, the Pfizer CEO said.

"When we see real-world data, will determine if the omicron is well covered by the third dose and for how long. And the second point, I think we will need a fourth dose," Bourla told CNBC's "Squawk Box."

Bourla previously projected that a fourth shot would be needed 12 months after the third dose. "With omicron we need to wait and see because we have very little information. We may need it faster," he said.

The Pfizer CEO said what's most important right now is to roll out third doses for the winter. Public health officials are worried about a spike in Covid infections as people gather more indoors to escape the cold.

https://www.google.com/amp/s/www.businessinsider.com/pfizer-fourth-vaccine-dose-to-combat-omicron-ceo-says-2021-12%3famp

Thieves.

Dem Don see business opportunity. Money making opportunity

una go take vaccine till una go yoo!

Are you ready for the boosters.

Let's go boosters.